Patent 10584175 was granted and assigned to La Trobe University on March, 2020 by the United States Patent and Trademark Office.
The present invention provides an isolated or recombinant Fn14-binding protein comprising an antigen binding do main, wherein the antigen binding domain binds specifically to Fn14 or a cell expressing Fn14.